Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
2020 · Cell · 1,564 citations
https://doi.org/10.1016/j.cell.2020.08.001
B
Benjamin Krämer
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
314
Papers
11.3K
Citations
48
h-index
135
i10-index
Benjamin Krämer is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Chronic Obstructive Pulmonary Disease (COPD) Research & Immune Cell Function and Interaction & Respiratory Support and Mechanisms. The author has an h-index of 48, co-authored 267 publications.
ORCID: 0000-0002-1385-9709Papers by this author
worksDisease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
2021 · Genome Medicine · 267 citations
https://doi.org/10.1186/s13073-020-00823-5
Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study
2010 · BMC Pulmonary Medicine · 118 citations
https://doi.org/10.1186/1471-2466-10-11
Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches
2011 · Respiratory Research · 46 citations
https://doi.org/10.1186/1465-9921-12-54
TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients
2012 · BMC Cancer · 22 citations
https://doi.org/10.1186/1471-2407-12-85
CXCR3(+)CD56Bright NK cells have strong anti-fibrotic potential.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0038846.g002
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat